daunorubicin has been researched along with Pseudotumor Cerebri in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aggarwal, M; Dass, J; Dhawan, R; Kumar, P; Mahapatra, M; Seth, T; Tyagi, S; Vaid, T; Viswanathan, GK | 1 |
| Dabadghao, S; Melinkeri, SR; Mishra, SK | 1 |
2 other study(ies) available for daunorubicin and Pseudotumor Cerebri
| Article | Year |
|---|---|
Shifting gears to differentiation agents in acute promyelocytic leukemia with resource constraints-a cohort study.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Daunorubicin; Humans; Leukemia, Promyelocytic, Acute; Pseudotumor Cerebri; Retrospective Studies; Syndrome; Treatment Outcome; Tretinoin | 2022 |
Benign thymic hyperplasia after chemotherapy for acute myeloid leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Cytarabine; Daunorubicin; Female; Humans; Hyperplasia; Leukemia, Promyelocytic, Acute; Pseudotumor Cerebri; Radiography; Sweet Syndrome; Thymus Gland; Tretinoin | 2001 |